Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
KYNB · against 1,216 other Healthcare companies
Ranked #1,202 of 1,217 · scores higher than 0% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including KYNB · Click a bar to see the companies
Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | KYNB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -78.3% | 6.1% | 2% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -64.2% | 5.8% | 1% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,202 | 34M USD | 0 | 19 | |
| 1,202 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 454M AUD (≈$299M) |
| 0 |
| 7 |
| 1,202 | 172M USD | 0 | 3 |
| 1,202 | 149M USD | 0 | 10 |
| 1,202 | 17M USD | 0 | 10 |
| 1,202 | 1.6B USD | 0 | 7 |
| 1,202 | 1.2B USD | 0 | 21 |
| 1,202 | 57.0B INR (≈$684M) | 0 | 40 |